{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:01:36Z","timestamp":1789441296148,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T00:00:00Z","timestamp":1643587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2001203"],"award-info":[{"award-number":["APP2001203"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2001203"],"award-info":[{"award-number":["APP2001203"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2001203"],"award-info":[{"award-number":["APP2001203"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Curtin University School of Pharmacy and Biomedical Science","award":["Early\/Mid-career research grant"],"award-info":[{"award-number":["Early\/Mid-career research grant"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Advanced biological aging, as assessed through DNA methylation markers, is associated with several complex diseases. The associations between maternal DNA methylation age and preeclampsia (PE) have not been fully assessed. The aim of this study was to examine if increased maternal DNA methylation age (<jats:italic>DNAm<\/jats:italic>Age) was shown to be accelerated in women with PE when compared to women who had normotensive pregnancies. The case\/control cohort available for study consisted of 166 women (89 with normotensive pregnancy, 77 with PE) recruited previously at the Royal Women\u2019s Hospital in Melbourne, Australia. DNA methylation profiles were obtained using the Illumina EPIC Infinium array for analysis of genomic DNA isolated from whole blood. These profiles were used to calculate seven estimates of <jats:italic>DNAm<\/jats:italic>Age and included (1) Horvath, (2) Hannum, (3) Horvath Skin and Blood, (4) Wu, (5) PhenoAge, (6) telomere length and (7) GrimAge and its surrogate measures. Three measures of DNA methylation age acceleration were calculated for all seven measures using linear regression. Pearson's correlation was performed to investigate associations between chronological age and <jats:italic>DNAm<\/jats:italic>Age. Differences between chronological age and <jats:italic>DNAm<\/jats:italic>Age and epigenetic age acceleration were investigated using t-tests. No significant difference was observed for chronological age between women with PE (age\u2009=\u200930.53\u2009\u00b1\u20095.68) and women who had normotensive pregnancies (age\u2009=\u200931.76\u2009\u00b1\u20094.76). All seven <jats:italic>DNAm<\/jats:italic>Age measures were significantly correlated (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) with chronological age. After accounting for multiple testing and investigating differences in <jats:italic>DNAm<\/jats:italic>Age between normotensive women and women with PE, only Wu <jats:italic>DNAm<\/jats:italic>Age was significant (<jats:italic>p<\/jats:italic>\u2009=\u20090.001). When examining differences for epigenetic age acceleration between PE and normotensive women Hannum, Wu, and PhenoAge <jats:italic>DNAm<\/jats:italic>Age estimates (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) were significant for both epigenetic age acceleration and intrinsic acceleration models. We found that accelerated maternal <jats:italic>DNAm<\/jats:italic>Age is increased in women with PE in some models of epigenetic aging. This research underlines the importance for further investigation into the potential changes of differential DNA methylation in PE.<\/jats:p>","DOI":"10.1038\/s41598-022-05744-4","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T11:18:28Z","timestamp":1643627908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of epigenetic age calculators between preeclampsia and normotensive pregnancies in an Australian cohort"],"prefix":"10.1038","volume":"12","author":[{"given":"Paulina","family":"Pruszkowska-Przybylska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Brennecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric K.","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip E.","family":"Melton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"5744_CR1","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0140-6736(16)31470-2","volume":"388","author":"GBD 2015","year":"2016","unstructured":"GBD 2015. Maternal mortality collaborators, global, regional, and national levels of maternal mortality, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388, 1775\u20131812. https:\/\/doi.org\/10.1016\/S0140-6736(16)31470-2 (2016).","journal-title":"Lancet"},{"key":"5744_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/s0029-7844(02)02314-1","volume":"101","author":"KA Boggess","year":"2003","unstructured":"Boggess, K. A. et al. Maternal periodontal disease is associated with an increased risk for preeclampsia. Obstet. Gynecol. 101, 227\u2013231. https:\/\/doi.org\/10.1016\/s0029-7844(02)02314-1 (2003).","journal-title":"Obstet. Gynecol."},{"key":"5744_CR3","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1001\/jama.287.24.3183","volume":"287","author":"KY Lain","year":"2002","unstructured":"Lain, K. Y. & Roberts, J. M. Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA 287, 3183\u20133186. https:\/\/doi.org\/10.1001\/jama.287.24.3183 (2002).","journal-title":"JAMA"},{"key":"5744_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/ajmg.a.30257","volume":"130A","author":"S Cnattingius","year":"2004","unstructured":"Cnattingius, S., Reilly, M., Pawitan, Y. & Lichtenstein, P. Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study. Am. J. Med. Genet. A 130A, 365\u2013371. https:\/\/doi.org\/10.1002\/ajmg.a.30257 (2004).","journal-title":"Am. J. Med. Genet. A"},{"key":"5744_CR5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1056\/NEJM200103223441201","volume":"344","author":"MS Esplin","year":"2001","unstructured":"Esplin, M. S. et al. Paternal and maternal components of the predisposition to preeclampsia. N. Engl. J. Med. 344, 867\u2013872. https:\/\/doi.org\/10.1056\/NEJM200103223441201 (2001).","journal-title":"N. Engl. J. Med."},{"key":"5744_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1471-0528.2004.00042x.x","volume":"111","author":"E Nilsson","year":"2004","unstructured":"Nilsson, E., Ros, H. S., Cnattingius, S. & Lichtenstein, P. The importance of genetic and environmental effects for pre-eclampsia and gestational hypertension: a family study. BJOG 111, 200\u2013206. https:\/\/doi.org\/10.1111\/j.1471-0528.2004.00042x.x (2004).","journal-title":"BJOG"},{"key":"5744_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12884-015-0754-2","volume":"15","author":"LT Roten","year":"2015","unstructured":"Roten, L. T. et al. The Norwegian preeclampsia family cohort study: a new resource for investigating genetic aspects and heritability of preeclampsia and related phenotypes. BMC Pregnancy Childbirth 15, 319. https:\/\/doi.org\/10.1186\/s12884-015-0754-2 (2015).","journal-title":"BMC Pregnancy Childbirth"},{"key":"5744_CR8","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1097\/HJH.0000000000000696","volume":"33","author":"LC Thomsen","year":"2015","unstructured":"Thomsen, L. C. et al. Refined phenotyping identifies links between preeclampsia and related diseases in a Norwegian preeclampsia family cohort. J. Hypertens 33, 2294\u20132302. https:\/\/doi.org\/10.1097\/HJH.0000000000000696 (2015).","journal-title":"J. Hypertens"},{"key":"5744_CR9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.preghy.2020.01.013","volume":"19","author":"L Ding","year":"2020","unstructured":"Ding, L. et al. PHLDA2 gene polymorphisms and risk of HELLP syndrome and severe preeclampsia. Pregnancy Hypertens. 19, 190\u2013194. https:\/\/doi.org\/10.1016\/j.preghy.2020.01.013 (2020).","journal-title":"Pregnancy Hypertens."},{"key":"5744_CR10","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/HJH.0000000000002023","volume":"37","author":"PE Melton","year":"2019","unstructured":"Melton, P. E. et al. Whole-exome sequencing in multiplex preeclampsia families identifies novel candidate susceptibility genes. J. Hypertens. 37, 997\u20131011. https:\/\/doi.org\/10.1097\/HJH.0000000000002023 (2019).","journal-title":"J. Hypertens."},{"key":"5744_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.gene.2019.04.036","volume":"704","author":"J Mishra","year":"2019","unstructured":"Mishra, J. et al. Differential global and MTHFR gene specific methylation patterns in preeclampsia and recurrent miscarriages: A case-control study from North India. Gene 704, 68\u201373. https:\/\/doi.org\/10.1016\/j.gene.2019.04.036 (2019).","journal-title":"Gene"},{"key":"5744_CR12","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fgene.2020.00171","volume":"11","author":"Y Salameh","year":"2020","unstructured":"Salameh, Y., Bejaoui, Y. & El Hajj, N. DNA methylation biomarkers in aging and age-related diseases. Front. Genet 11, 171. https:\/\/doi.org\/10.3389\/fgene.2020.00171 (2020).","journal-title":"Front. Genet"},{"key":"5744_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fbioe.2019.00388","volume":"7","author":"T Zhu","year":"2019","unstructured":"Zhu, T. et al. CancerClock: A DNA methylation age predictor to identify and characterize aging clock in pan-cancer. Front. Bioeng. Biotechnol. 7, 388. https:\/\/doi.org\/10.3389\/fbioe.2019.00388 (2019).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"5744_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.118.002089","volume":"11","author":"MM Mendelson","year":"2018","unstructured":"Mendelson, M. M. Epigenetic age acceleration: a biological doomsday clock for cardiovascular disease?. Circ. Genom. Precis. Med. 11, e002089. https:\/\/doi.org\/10.1161\/CIRCGEN.118.002089 (2018).","journal-title":"Circ. Genom. Precis. Med."},{"key":"5744_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/aje\/kwx291","volume":"187","author":"PA Dugue","year":"2018","unstructured":"Dugue, P. A. et al. Association of DNA methylation-based biological age with health risk factors and overall and cause-specific mortality. Am. J. Epidemiol. 187, 529\u2013538. https:\/\/doi.org\/10.1093\/aje\/kwx291 (2018).","journal-title":"Am. J. Epidemiol."},{"key":"5744_CR16","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, R115. https:\/\/doi.org\/10.1186\/gb-2013-14-10-r115 (2013).","journal-title":"Genome Biol."},{"key":"5744_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.molcel.2012.10.016","volume":"49","author":"G Hannum","year":"2013","unstructured":"Hannum, G. et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell 49, 359\u2013367. https:\/\/doi.org\/10.1016\/j.molcel.2012.10.016 (2013).","journal-title":"Mol. Cell"},{"key":"5744_CR18","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.18632\/aging.101508","volume":"10","author":"S Horvath","year":"2018","unstructured":"Horvath, S. et al. Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies. Aging (Albany NY) 10, 1758\u20131775. https:\/\/doi.org\/10.18632\/aging.101508 (2018).","journal-title":"Aging (Albany NY)"},{"key":"5744_CR19","doi-asserted-by":"publisher","first-page":"10031","DOI":"10.18632\/aging.102399","volume":"11","author":"X Wu","year":"2019","unstructured":"Wu, X. et al. DNA methylation profile is a quantitative measure of biological aging in children. Aging (Albany NY) 11, 10031\u201310051. https:\/\/doi.org\/10.18632\/aging.102399 (2019).","journal-title":"Aging (Albany NY)"},{"key":"5744_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.18632\/aging.101414","volume":"10","author":"ME Levine","year":"2018","unstructured":"Levine, M. E. et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY) 10, 573\u2013591. https:\/\/doi.org\/10.18632\/aging.101414 (2018).","journal-title":"Aging (Albany NY)"},{"key":"5744_CR21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.18632\/aging.101684","volume":"11","author":"AT Lu","year":"2019","unstructured":"Lu, A. T. et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY) 11, 303\u2013327. https:\/\/doi.org\/10.18632\/aging.101684 (2019).","journal-title":"Aging (Albany NY)"},{"key":"5744_CR22","doi-asserted-by":"publisher","first-page":"5895","DOI":"10.18632\/aging.102173","volume":"11","author":"AT Lu","year":"2019","unstructured":"Lu, A. T. et al. DNA methylation-based estimator of telomere length. Aging (Albany NY) 11, 5895\u20135923. https:\/\/doi.org\/10.18632\/aging.102173 (2019).","journal-title":"Aging (Albany NY)"},{"key":"5744_CR23","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/biof.1542","volume":"45","author":"A Kamrani","year":"2019","unstructured":"Kamrani, A. et al. The role of epigenetic changes in preeclampsia. BioFactors 45, 712\u2013724. https:\/\/doi.org\/10.1002\/biof.1542 (2019).","journal-title":"BioFactors"},{"key":"5744_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2217\/epi-2016-0103","volume":"9","author":"BT Mayne","year":"2017","unstructured":"Mayne, B. T. et al. Accelerated placental aging in early onset preeclampsia pregnancies identified by DNA methylation. Epigenomics 9, 279\u2013289. https:\/\/doi.org\/10.2217\/epi-2016-0103 (2017).","journal-title":"Epigenomics"},{"key":"5744_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2393-12-47","volume":"12","author":"R Lamminpaa","year":"2012","unstructured":"Lamminpaa, R., Vehvilainen-Julkunen, K., Gissler, M. & Heinonen, S. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland 1997\u20132008. BMC Pregnancy Childbirth 12, 47. https:\/\/doi.org\/10.1186\/1471-2393-12-47 (2012).","journal-title":"BMC Pregnancy Childbirth"},{"key":"5744_CR26","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1055\/s-0039-1694794","volume":"37","author":"JJ Sheen","year":"2020","unstructured":"Sheen, J. J. et al. Maternal age and preeclampsia outcomes during delivery hospitalizations. Am. J. Perinatol. 37, 44\u201352. https:\/\/doi.org\/10.1055\/s-0039-1694794 (2020).","journal-title":"Am. J. Perinatol."},{"key":"5744_CR27","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1007\/s43032-021-00575-6","volume":"28","author":"LW Heinsberg","year":"2021","unstructured":"Heinsberg, L. W. et al. An exploratory study of epigenetic age in preeclamptic and normotensive pregnancy reveals differences by self-reported race but not pregnancy outcome. Reprod. Sci. 28, 3519\u20133528. https:\/\/doi.org\/10.1007\/s43032-021-00575-6 (2021).","journal-title":"Reprod. Sci."},{"key":"5744_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033666","volume":"7","author":"MP Johnson","year":"2012","unstructured":"Johnson, M. P. et al. Genome-wide association scan identifies a risk locus for preeclampsia on 2q14, near the inhibin, beta B gene. PLoS ONE 7, e33666. https:\/\/doi.org\/10.1371\/journal.pone.0033666 (2012).","journal-title":"PLoS ONE"},{"key":"5744_CR29","doi-asserted-by":"publisher","first-page":"700","DOI":"10.5694\/j.1326-5377.1993.tb121854.x","volume":"158","author":"MA Brown","year":"1993","unstructured":"Brown, M. A., Gallary, E. D. M., Gatt, S. P., Leslie, G. & Robinson, J. Management of hypertension in pregnancy: executive summary. Australasian society for the study of hypertension in pregnancy. Med. J. Aust. 158, 700\u2013702 (1993).","journal-title":"Med. J. Aust."},{"key":"5744_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1479-828x.2000.tb01136.x","volume":"40","author":"MA Brown","year":"2000","unstructured":"Brown, M. A. et al. The detection, investigation and management of hypertension in pregnancy: executive summary. Aust. N. Z. J. Obstet. Gynaecol. 40, 133\u2013138. https:\/\/doi.org\/10.1111\/j.1479-828x.2000.tb01136.x (2000).","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"5744_CR31","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1479-828X.2009.01003.x","volume":"49","author":"SA Lowe","year":"2009","unstructured":"Lowe, S. A. et al. Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust. N. Z. J. Obstet. Gynaecol. 49, 242\u2013246. https:\/\/doi.org\/10.1111\/j.1479-828X.2009.01003.x (2009).","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"5744_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13059-019-1664-9","volume":"20","author":"F Muller","year":"2019","unstructured":"Muller, F. et al. RnBeads 2.0: comprehensive analysis of DNA methylation data. Genome Biol. 20, 55. https:\/\/doi.org\/10.1186\/s13059-019-1664-9 (2019).","journal-title":"Genome Biol."},{"key":"5744_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/bioinformatics\/bts680","volume":"29","author":"AE Teschendorff","year":"2013","unstructured":"Teschendorff, A. E. et al. A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data. Bioinformatics 29, 189\u2013196. https:\/\/doi.org\/10.1093\/bioinformatics\/bts680 (2013).","journal-title":"Bioinformatics"},{"key":"5744_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12859-019-3307-2","volume":"21","author":"C Decamps","year":"2020","unstructured":"Decamps, C. et al. Guidelines for cell-type heterogeneity quantification based on a comparative analysis of reference-free DNA methylation deconvolution software. BMC Bioinf. 21, 16. https:\/\/doi.org\/10.1186\/s12859-019-3307-2 (2020).","journal-title":"BMC Bioinf."},{"key":"5744_CR35","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/bioinformatics\/btaa825","volume":"37","author":"D Pelegi-Siso","year":"2021","unstructured":"Pelegi-Siso, D., de Prado, P., Ronkainen, J., Bustamante, M. & Gonzalez, J. R. methylclock: a bioconductor package to estimate DNA methylation age. Bioinformatics 37, 1759\u20131760. https:\/\/doi.org\/10.1093\/bioinformatics\/btaa825 (2021).","journal-title":"Bioinformatics"},{"key":"5744_CR36","unstructured":"Team, R. R: A language and environment for statistical computing. (2018)."},{"key":"5744_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13148-020-00909-2","volume":"12","author":"KM Ross","year":"2020","unstructured":"Ross, K. M. et al. Epigenetic age and pregnancy outcomes: GrimAge acceleration is associated with shorter gestational length and lower birthweight. Clin. Epigenetics 12, 120. https:\/\/doi.org\/10.1186\/s13148-020-00909-2 (2020).","journal-title":"Clin. Epigenetics"},{"issue":"558","key":"5744_CR38","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1016\/j.ajog.2010.07.039","volume":"203","author":"Y Yogev","year":"2010","unstructured":"Yogev, Y. et al. Pregnancy outcome at extremely advanced maternal age. Am. J. Obstet. Gynecol. 203(558), e551-557. https:\/\/doi.org\/10.1016\/j.ajog.2010.07.039 (2010).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"5744_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000064689","volume":"54","author":"SM Ziadeh","year":"2002","unstructured":"Ziadeh, S. M. Maternal and perinatal outcome in nulliparous women aged 35 and older. Gynecol. Obstet. Invest. 54, 6\u201310. https:\/\/doi.org\/10.1159\/000064689 (2002).","journal-title":"Gynecol. Obstet. Invest."},{"key":"5744_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a017970","volume":"7","author":"M Herbert","year":"2015","unstructured":"Herbert, M., Kalleas, D., Cooney, D., Lamb, M. & Lister, L. Meiosis and maternal aging: insights from aneuploid oocytes and trisomy births. Cold Spring Harb. Perspect. Biol. 7, a017970. https:\/\/doi.org\/10.1101\/cshperspect.a017970 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"5744_CR41","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.18632\/aging.102124","volume":"11","author":"F Tekola-Ayele","year":"2019","unstructured":"Tekola-Ayele, F. et al. Sex differences in the associations of placental epigenetic aging with fetal growth. Aging (Albany NY) 11, 5412\u20135432. https:\/\/doi.org\/10.18632\/aging.102124 (2019).","journal-title":"Aging (Albany NY)"},{"key":"5744_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12851","volume":"79","author":"SB Cheng","year":"2018","unstructured":"Cheng, S. B., Davis, S. & Sharma, S. Maternal-fetal cross talk through cell-free fetal DNA, telomere shortening, microchimerism, and inflammation. Am. J. Reprod. Immunol. 79, e12851. https:\/\/doi.org\/10.1111\/aji.12851 (2018).","journal-title":"Am. J. Reprod. Immunol."},{"key":"5744_CR43","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1177\/1933719115592714","volume":"22","author":"M Phillippe","year":"2015","unstructured":"Phillippe, M. Cell-free fetal DNA, telomeres, and the spontaneous onset of parturition. Reprod. Sci. 22, 1186\u20131201. https:\/\/doi.org\/10.1177\/1933719115592714 (2015).","journal-title":"Reprod. Sci."},{"key":"5744_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1600-0897.2009.00697.x","volume":"61","author":"AH Liao","year":"2009","unstructured":"Liao, A. H., Liu, L. P., Ding, W. P. & Zhang, L. Functional changes of human peripheral B-lymphocytes in pre-eclampsia. Am. J. Reprod. Immunol. 61, 313\u2013321. https:\/\/doi.org\/10.1111\/j.1600-0897.2009.00697.x (2009).","journal-title":"Am. J. Reprod. Immunol."},{"key":"5744_CR45","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.1600-0897.2012.01120.x","volume":"67","author":"A Fukui","year":"2012","unstructured":"Fukui, A. et al. Changes of NK cells in preeclampsia. Am. J. Reprod. Immunol. 67, 278\u2013286. https:\/\/doi.org\/10.1111\/j.1600-0897.2012.01120.x (2012).","journal-title":"Am. J. Reprod. Immunol."},{"key":"5744_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081651","author":"Y Ye","year":"2017","unstructured":"Ye, Y. et al. Role of plasminogen activator inhibitor type 1 in pathologies of female reproductive diseases. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms18081651 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"5744_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056907","volume":"8","author":"JA Morgan","year":"2013","unstructured":"Morgan, J. A., Bombell, S. & McGuire, W. Association of plasminogen activator inhibitor-type 1 (-675 4G\/5G) polymorphism with pre-eclampsia: systematic review. PLoS ONE 8, e56907. https:\/\/doi.org\/10.1371\/journal.pone.0056907 (2013).","journal-title":"PLoS ONE"},{"key":"5744_CR48","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1053\/plac.2002.0828","volume":"23","author":"T Clausen","year":"2002","unstructured":"Clausen, T. et al. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia. Circulating markers of disturbed placentation?. Placenta 23, 380\u2013385. https:\/\/doi.org\/10.1053\/plac.2002.0828 (2002).","journal-title":"Placenta"},{"key":"5744_CR49","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1182\/blood.V74.4.1332.1332","volume":"74","author":"A Estelles","year":"1989","unstructured":"Estelles, A., Gilabert, J., Aznar, J., Loskutoff, D. J. & Schleef, R. R. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia. Blood 74, 1332\u20131338 (1989).","journal-title":"Blood"},{"key":"5744_CR50","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1159\/000292703","volume":"35","author":"SC Koh","year":"1993","unstructured":"Koh, S. C., Anandakumar, C., Montan, S. & Ratnam, S. S. Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia. Gynecol. Obstet. Invest. 35, 214\u2013221. https:\/\/doi.org\/10.1159\/000292703 (1993).","journal-title":"Gynecol. Obstet. Invest."},{"key":"5744_CR51","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1067\/mob.2002.126280","volume":"187","author":"EM Roes","year":"2002","unstructured":"Roes, E. M. et al. Levels of plasminogen activators and their inhibitors in maternal and umbilical cord plasma in severe preeclampsia. Am. J. Obstet. Gynecol. 187, 1019\u20131025. https:\/\/doi.org\/10.1067\/mob.2002.126280 (2002).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"5744_CR52","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.preghy.2019.02.003","volume":"16","author":"CA Whigham","year":"2019","unstructured":"Whigham, C. A. et al. Circulating adrenomedullin mRNA is decreased in women destined to develop term preeclampsia. Pregnancy Hypertens. 16, 16\u201325. https:\/\/doi.org\/10.1016\/j.preghy.2019.02.003 (2019).","journal-title":"Pregnancy Hypertens."},{"key":"5744_CR53","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/hr.2011.9","volume":"34","author":"WL Gao","year":"2011","unstructured":"Gao, W. L. et al. Detection of global DNA methylation and paternally imprinted H19 gene methylation in preeclamptic placentas. Hypertens. Res. 34, 655\u2013661. https:\/\/doi.org\/10.1038\/hr.2011.9 (2011).","journal-title":"Hypertens. Res."},{"key":"5744_CR54","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/dna.2010.1084","volume":"30","author":"A Kulkarni","year":"2011","unstructured":"Kulkarni, A., Chavan-Gautam, P., Mehendale, S., Yadav, H. & Joshi, S. Global DNA methylation patterns in placenta and its association with maternal hypertension in pre-eclampsia. DNA Cell Biol. 30, 79\u201384. https:\/\/doi.org\/10.1089\/dna.2010.1084 (2011).","journal-title":"DNA Cell Biol."},{"key":"5744_CR55","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.molcel.2018.08.008","volume":"71","author":"AE Field","year":"2018","unstructured":"Field, A. E. et al. DNA methylation clocks in aging: categories, causes, and consequences. Mol. Cell. 71, 882\u2013895. https:\/\/doi.org\/10.1016\/j.molcel.2018.08.008 (2018).","journal-title":"Mol. Cell."},{"key":"5744_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1008104","volume":"15","author":"J Gibson","year":"2019","unstructured":"Gibson, J. et al. A meta-analysis of genome-wide association studies of epigenetic age acceleration. PLoS Genet. 15, e1008104. https:\/\/doi.org\/10.1371\/journal.pgen.1008104 (2019).","journal-title":"PLoS Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05744-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05744-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T22:30:04Z","timestamp":1669329004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-05744-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5744"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-05744-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"assertion":[{"value":"11 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1664"}}